Accendra Health
217 hedge funds and large institutions have $1.09B invested in Accendra Health in 2023 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 70 increasing their positions, 79 reducing their positions, and 37 closing their positions.
2.48% more ownership
Funds ownership: 94.93% → 97.41% (+2.5%)
3% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 37
0% more funds holding
Funds holding: 217 → 217 (0)
11% less repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 79
23% less capital invested
Capital invested by funds: $1.41B → $1.09B (-$328M)
56% less call options, than puts
Call options by funds: $2.55M | Put options by funds: $5.83M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$48.2M |
| 2 |
Janus Henderson Group
London,
|
+$18.4M |
| 3 |
D.E. Shaw & Co
New York
|
+$8.78M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
+$7.24M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$4.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$47.4M |
| 2 |
William Blair Investment Management
Chicago,
Illinois
|
-$38.7M |
| 3 |
Brown Advisory
Baltimore,
Maryland
|
-$27.8M |
| 4 |
Charles Schwab
San Francisco,
California
|
-$7.01M |
| 5 |
Renaissance Technologies
New York
|
-$5.64M |
ACH Hedge Fund Activity: Q1 2023 in Review
217 of the 6,286 institutional investors tracked by Wall St. Rank reported a position in Accendra Health (ACH) for Q1 2023, worth a combined $1.09B — down 23% from $1.41B a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new ACH positions and 37 closed out — a net gain of 1 holder — while 70 added to existing stakes and 79 trimmed.
The largest buyer was Deerfield Management, adding an estimated $48.2M. The largest seller was Wellington Management Group, cutting an estimated $47.4M.
- 217 institutional investors held Accendra Health (ACH) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $1.09B of Accendra Health stock for Q1 2023, down 23% quarter-over-quarter.
- 38 funds opened new Accendra Health positions in Q1 2023 and 37 closed out, a net change of +1 holder.
- The largest Accendra Health buyer in Q1 2023 was Deerfield Management, an estimated $48.2M added.
- The largest Accendra Health seller in Q1 2023 was Wellington Management Group, an estimated $47.4M sold.
Based on aggregated 13F filings for Q1 2023.